MY FAVORITE PAGES

Saturday, October 17, 2015

Drug Problems: Dangerous Decision-Making at the FDA



A new POGO investigation has found that the FDA took a lax or permissive approach in approving the prescription blood thinner Pradaxa

Drug Problems:
Dangerous Decision-Making at the FDA

How much comfort should medical consumers take from the words “FDA approved”?
In judgment call after judgment call involving the prescription blood thinner Pradaxa, which has been named as a suspect in thousands of patient deaths, the FDA took a lax or permissive approach, a Project On Government Oversight investigation has found.


John Sopko
Beginning to impose conditions on our aid to Afghanistan may help incentivize systemic changes within the Afghan government, especially in the areas of sexual abuse prevention and anti-corruption.

GSA IT to GSA ProfIT
The General Services Administration charges other agencies fees when they use GSA-established contracts. Those fees have provided a slush fund to GSA that exceeds $1 billion.

From the World of POGO

Tell President Obama: Veto the Defense Bill

Tell President Obama to Veto the National Defense Authorization Act (NDAA)

The NDAA contains budget gimmicks to inflate Pentagon spending beyond the legal caps and several provisions that actually weaken oversight of the Pentagon’s $612 billion budget. It also fails to modernize our antiquated system of protections for military whistleblowers.
Take action

10-21-2015 - You're invited to our Beth Daley Casino Night!
Please join us Wednesday, October 21 for a Speakeasy Casino Night in DC. Proceeds from this event will support the Beth Daley Impact Fellowship Fund and help POGO nurture a new generation of government accountability advocates.
Purchase tickets or support the fellowship
facebook_button-01.pngtwitter_button-01.pngpodcast_button-01.pngrss_button-01.png
DonateFour Star Charity from Charity Navigator2015 Great Nonprofits Badge
POGO :: 1100 G Street, NW, Suite 500 :: Washington, DC 20005 :: (202) 347-1122
The TRUTH will set you FREE.

No comments:

Post a Comment